Network to Understand Reproductive Rheumatology Registry
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT06940869
- Status
- Enrolling By Invitation
Conditions
- Autoimmune Diseases
- Pregnancy Interest
- Pregnancy Related
- Reproductive Health
- Rheumatic Diseases
Eligibility Criteria
- Sex
- FEMALE
- Age
- 12 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- NURTURE Registry — OTHERTo improve pregnancy and birth outcomes for women with rheumatic diseases and to understand risk factors associated with poor pregnancy outcomes.
Study Details
The purpose of the NURTURE Registry is to enroll those who are pregnant and/or potentially capable of pregnancy. Participants will complete patient-reported surveys at enrollment and periodically prior to conception, during pregnancy, and following the completion of the study pregnancy. The study rheumatologist will provide the patient's diagnosis and record rheumatic disease activity at each clinic visit. Medication use, vital signs, and routine laboratory assessments will be collected throughout this period. Pregnancy, maternal, and infant outcomes will be obtained through the electronic medical record and from patient-reported surveys. This Registry will provide a rich data repository for research to improve pregnancy and birth outcomes for women with rheumatic diseases and will be used in on-going and future research to better understand the risk factors that are associated with poor pregnancy outcomes, including preterm birth, intrauterine growth restriction, and preeclampsia, as well as the effects of medication on disease management in pregnancy. Infant outcomes, medications, provider care, pregnancy planning, and social determinants of health on pregnancy and pregnancy outcomes will also be collected. The majority of the information collected in NURTURE, such as labs, disease activity, and medications, PRO's will originate from the EHR. Upon consent, participants will complete an enrollment survey that will include relevant patient reported measures. No study visits outside of routine care will occur. Participants may also complete a yearly survey about their reproductive health journey. The registry will be ongoing and will include periodic analysis of clinical data within this protocol. Additional analysis will be covered under seperate IRB approved protocols. Enrollment in the registry does not significantly increase the risk for a patient.
Key Dates
- Start date
- May 19, 2025
- Status verified
- May 2026
- Primary completion
- Jan 1, 2035
- Completion
- Jan 1, 2035
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Edinburgh post-partum depression scale [ Time Frame: up to 20 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke Medical Center | Durham | North Carolina | 27710 | - |
Find similar trials in Durham, NC
Related Studies
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)Recruiting · Center for International Blood and Marrow Transplant Research · Birmingham, Alabama
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruiting · Duke University · Durham, North Carolina
- Patient Centered Simulation For Labor and DeliveryNot Yet Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Observational Pharmaco-Epidemiology Research & AnalysisRecruiting · Epividian · Durham, North Carolina